M. Marcq

Use of a Comprehensive Geriatric Assessment for the Management of Elderly Patients With Advanced Non–Small-Cell Lung Cancer: The Phase III Randomized ESOGIA-GFPC-GECP 08-02 Study

R. Corre, Laurent Greillier, H. Le Caer et al. · Journal of Clinical Oncology · 2016 · 407 citations

Medicine, Geriatric Medicine, Oncology +17

Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease: A Nationwide, Multicenter Cohort Study

Alice Tison, Gilles Quéré, L. Misery et al. · Arthritis & Rheumatology · 2019 · 312 citations · Full text

Life Sciences, Immunology, Oncology +16

Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study

Luis Paz‐Ares, Óscar Juan, Giannis Mountzios et al. · Journal of Clinical Oncology · 2024 · 115 citations · Full text

Medicine, Oncology, Pharmacology +17

Clinical validation of a prognostic tool in a population of outpatients treated for incurable cancer undergoing anticancer therapy: PRONOPALL study

Hugues Bourgeois, Françoise Grudé, P. Solal-Céligny et al. · Annals of Oncology · 2017 · 51 citations · Full text

Medicine, Oncology, Palliative Care +9

Efficacy of Osimertinib in EGFR-Mutated Non-Small Cell Lung Cancer with Leptomeningeal Metastases Pretreated with EGFR-Tyrosine Kinase Inhibitors

K. Saboundji, J.B. Auliac, Maurice Pérol et al. · Targeted Oncology · 2018 · 43 citations

Medicine, Oncology, Pharmacology +16